Chapter 492 - 281: An Invitation from the Director of a World-Class Cardiac Specialty Hospital
Chapter 492: Chapter 281: An Invitation from the Director of a World-Class Cardiac Specialty Hospital
James, still savoring Wu Ting’s article, immediately instructed his assistant to schedule its publication in the next issue of the *Journal of the American College of Cardiology (JACC)*.
After checking the time, Professor James saw that he had an important patient consultation to attend.
When James arrived at the consultation room, the other two department heads were already prepared.
The patient was a six-year-old girl whose grandfather was Professor Owen of the Berkeley Physics Department. Thanks to his neutrino collision technology, Professor Owen was currently a highly sought-after figure in the world of physics.
The Neutrino project, a collaboration with Edwards, was merely one application of his technology.
Professor Owen’s son was also a typical elite of the Southern Country, serving as the current deputy director of the national health bureau. Therefore, this patient was extremely important to Professor James.
Cleveland Hospital’s cardiac surgery department was number one in the Southern Country, a world-class, prestigious specialized heart hospital!
And James, as the dean, was an absolute authority on cardiac surgery in the Southern Country.
James had specially assembled a surgical team for this high-ranking official’s daughter, a clear indication of how seriously he was taking the case.
Following a junior doctor’s briefing, the team began to discuss the patient’s condition.
An Qier, age six, had been diagnosed with a rare aortic aneurysm. Its location was unusual and quite concealed. It was only thanks to Cleveland Hospital—with the world’s most advanced diagnostic technology and the best cardiac surgeons—that it had been diagnosed at such an early stage.
In severe cases, this type of rare aortic aneurysm could lead to life-threatening complications, including rupture, embolism in distal organs, or compression of adjacent organs.
The mortality risk skyrockets if the aneurysm ruptures, with the death rate exceeding 90%!
After careful examination and discussion, the top-tier doctors proposed traditional open surgery as the solution.
This would involve open aortic aneurysm resection combined with an artificial vessel graft, a procedure that could effectively cure the aneurysm and reduce the risk of recurrence.
However, while this approach could improve the patient’s long-term quality of life, it had drawbacks: it was highly invasive and carried a high risk of complications.
Furthermore, examinations revealed the patient was very young and had a weak constitution. She also had severe allergies and was prone to keloid scarring.
If they were to perform open surgery, there was a significant concern that her postoperative recovery would be poor.
One of the attending physicians proposed:
"Open surgery is feasible, but it isn’t the optimal surgical plan. What about using the state-of-the-art Endoscopic Surgical Instrument Control System developed by Professor Watanabe Yu’s team? It’s the most advanced minimally invasive technology available."
Cleveland Hospital, of course, had a deep collaborative relationship with Professor Watanabe Yu.
Hearing his subordinate’s suggestion, James, who was well-versed in all manner of advanced technologies, shook his head.
"Watanabe Yu’s system is indeed minimally invasive and results in fewer complications, which would be ideal for a patient with severe allergies and a tendency for scarring. However, the system is still very limited in the types of surgeries it can be used for."
"Moreover, robotic surgery requires a significant learning curve, and this is not a routine case. An Qier’s rare aneurysm is also in an extremely concealed location. Reaching it with any precision would require navigating around numerous organs and tissues."
"The Endoscopic Surgical Instrument Control System operates through small incisions. For an aneurysm located this deep, it’s clearly not an effective method. We wouldn’t be able to get a good field of view, and it would be difficult to perform all the necessary maneuvers with the robotic arms."
After dismissing Watanabe Yu’s proposal, James suddenly recalled Wu Ting’s paper. In *Hybrid Technology Typing: Research on Diversified Treatment Options,* a completely new, improved combination approach was mentioned.
It involved using the fourth-generation bioresorbable polymer vascular stent, independently developed by Wu Ting, in conjunction with a controllable, self-expanding valve delivery system, all supplemented by traditional surgical techniques to create a form of Hybrid Technology!
The more James thought about it, the more he felt that this Hybrid Technology was the best surgical option for An Qier.
Unfortunately, the Southern Country had not yet imported the fourth-generation bioresorbable polymer vascular stent and the controllable, self-expanding valve delivery system from Wu’s Pharmaceutical Company.
Cleveland Hospital had always been at the forefront of medical technology. It was unexpected that they would now need to seek help from Dr. Wu Ting in Jin Country.
James immediately presented his thoughts and reasoning to his specialized surgical team.
"This is a surgical approach from Jin Country Fuwai Hospital known as Hybrid Technology. Access is gained through the femoral artery to insert a specialized fourth-generation bioresorbable polymer vascular stent. This stent creates a new channel for blood flow, perfectly isolating the aortic aneurysm and preventing it from rupturing under the high pressure of the aortic bloodstream."
"Since it’s a bioresorbable vascular stent, it also eliminates the need for a future retrieval procedure."
"Then, we would use the new, controllable, self-expanding delivery system to repair the aortic aneurysm cavity... If we use this approach, we can achieve a perfectly minimally invasive procedure with a fast recovery!"
Listening to Dean James’s explanation, the others were filled with admiration.
"Incredible! The scientist who developed this bioresorbable vascular stent and controllable, self-expanding delivery system is an absolute genius!"